Ibaraki, Japan

Yoshihiko Hisatake


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Kounan, JP (1983)
  • Kohnan, JP (1985)
  • Ibaraki, JP (1993 - 2007)

Company Filing History:


Years Active: 1983-2007

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator in Biotechnology: Yoshihiko Hisatake

Introduction: Yoshihiko Hisatake is a prominent inventor located in Ibaraki, Japan. With a remarkable five patents to his name, Hisatake has made significant contributions to the field of biotechnology, particularly in the production of vital medicinal compounds.

Latest Patents: His latest innovations focus on the development of methylcobalamin, a form of vitamin B12 that is crucial in various medical applications. The first patent details an industrially efficient and environmentally friendly process for producing methylcobalamin. This involves reducing cyanocobalamin or hydroxocobalamin in the presence of a reducing agent, followed by methylation using a water-soluble methylating agent. The second patent further enhances this process, emphasizing methylation steps that utilize cyanocobalamin or hydroxocobalamin with the same chemical agents for improved production efficiency.

Career Highlights: Yoshihiko Hisatake is associated with Eisai Company, Limited, a noteworthy pharmaceutical company. His work in the company showcases his commitment to advancing medical science and improving healthcare outcomes through innovative processes.

Collaborations: Throughout his career, Hisatake has collaborated with distinguished colleagues, including Mikio Uchiyama and Takashi Sato. These partnerships have played a significant role in the research and development of valuable medicinal products and processes.

Conclusion: Yoshihiko Hisatake's inventive spirit and focus on the production of methylcobalamin position him as a vital contributor to the field of biotechnology. His patents not only highlight his technical expertise but also reflect his commitment to creating practical solutions that benefit human health. His ongoing work at Eisai Company, Limited, alongside esteemed colleagues, signals a promising future for further innovations in medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…